CRISPR Therapeutics AG (CRSP)
55.89
+0.82
(+1.49%)
USD |
NASDAQ |
May 03, 16:00
56.10
+0.21
(+0.38%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap: 4.744B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 4.744B |
| May 02, 2024 | 4.675B |
| May 01, 2024 | 4.568B |
| April 30, 2024 | 4.498B |
| April 29, 2024 | 4.654B |
| April 26, 2024 | 4.576B |
| April 25, 2024 | 4.561B |
| April 24, 2024 | 4.724B |
| April 23, 2024 | 4.788B |
| April 22, 2024 | 4.725B |
| April 19, 2024 | 4.673B |
| April 18, 2024 | 4.767B |
| April 17, 2024 | 4.716B |
| April 16, 2024 | 4.920B |
| April 15, 2024 | 4.984B |
| April 12, 2024 | 5.150B |
| April 11, 2024 | 5.340B |
| April 10, 2024 | 5.241B |
| April 09, 2024 | 5.534B |
| April 08, 2024 | 5.440B |
| April 05, 2024 | 5.331B |
| April 04, 2024 | 5.514B |
| April 03, 2024 | 5.475B |
| April 02, 2024 | 5.511B |
| April 01, 2024 | 5.778B |
| Date | Value |
|---|---|
| March 28, 2024 | 5.776B |
| March 27, 2024 | 5.946B |
| March 26, 2024 | 6.014B |
| March 25, 2024 | 6.024B |
| March 22, 2024 | 6.069B |
| March 21, 2024 | 6.314B |
| March 20, 2024 | 6.181B |
| March 19, 2024 | 6.098B |
| March 18, 2024 | 6.057B |
| March 15, 2024 | 6.182B |
| March 14, 2024 | 5.781B |
| March 13, 2024 | 6.003B |
| March 12, 2024 | 6.045B |
| March 11, 2024 | 6.167B |
| March 08, 2024 | 6.335B |
| March 07, 2024 | 6.372B |
| March 06, 2024 | 6.489B |
| March 05, 2024 | 6.502B |
| March 04, 2024 | 6.562B |
| March 01, 2024 | 6.723B |
| February 29, 2024 | 6.761B |
| February 28, 2024 | 7.039B |
| February 27, 2024 | 7.154B |
| February 26, 2024 | 6.909B |
| February 23, 2024 | 6.742B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.882B
Minimum
May 31 2019
15.53B
Maximum
Jan 14 2021
5.444B
Average
4.788B
Median
Dec 11 2023
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 103.60B |
| Intellia Therapeutics Inc | 2.268B |
| Novartis AG | 198.47B |
| AC Immune SA | 236.37M |
| Addex Therapeutics Ltd | 9.566M |
Market Cap Related Metrics
| Price to Book Value | 2.519 |
| Price | 55.89 |
| Earnings Yield | -3.45% |